🧠 AI clinical summary is being generated for this article and will appear shortly.
Source
NICE
Published
25 Mar 2026
Last Indexed
25 Mar 2026
Specialty
Neurology
NICE NG97 provides comprehensive guidance on the assessment, diagnosis, management and support of people with dementia and their carers.
Key Recommendations
- Diagnose dementia using cognitive testing (MMSE, MoCA) and imaging as appropriate
- Offer AChE inhibitors (donepezil, rivastigmine, galantamine) for mild-moderate Alzheimer's
- Memantine for moderate-severe Alzheimer's or if AChE inhibitors not tolerated
- Post-diagnostic support including dementia adviser and carer support
- Review antipsychotics every 3 months — avoid or minimise due to increased mortality risk
- Advance care planning discussions early in the disease course
- Structured activity and cognitive stimulation therapy for mild-moderate dementia
ClinicalIQ Editorial Note: This guideline summary is indexed from NICE. Always refer to the full guideline for complete recommendations. Last indexed: 25 Mar 2026